Novavax emits signals of weakness - Analysis - 31-03-2023

Novavax's stock (NVAX) fell in the intraday levels, marking a loss of 1.05% in the last session, or 7 cents, and settling at 6.59, amid the dominance of the main downward trend in the medium and short terms, with negative pressure from the 50-day SMA, coupled with negative signals from the RSI after reaching overbought levels, hinting at negative divergence. 

Therefore we expect more losses for the stock, targeting the support of 4.00, provided the resistance of 8.85 holds on.

Expected trend for today: Bearish